PCSK9 Antibody Dramatically Lowers LDL
XARELTO PI Information. PCSK9 Inhibition in Patients With Primary Hypercholesterolemia on Atorvastatin.
Christopher P. Cannon, M.D., F.A.C.C.
James McKenney, Pharm.D.
Statements or opinions expressed in this program reflects the views of the contributors
and
do not reflect the official policy of the ACCF, unless otherwise noted.